Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles W Stratton

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Emerging Infectious Diseases|January 21, 2003
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistanceCharles W Stratton
The Medical Clinics of North America|November 23, 2006
In vitro susceptibility testing versus in vivo effectivenessCharles W Stratton
Expert Review of Anti-Infective Therapy|October 16, 2004
Antimicrobial resistance in respiratory tract pathogensCharles W Stratton
Postgraduate Medicine|August 12, 2009
Meeting the challenge of antibiotic resistance: The PROTEKT US studyCharles W Stratton
The Journal of Infectious Diseases|December 24, 2016
Phages, Fitness, Virulence, and Synergy: A Novel Approach for the Therapy of Infections Caused by Pseudomonas aeruginosaCharles W Stratton
Microbes and Infection|November 19, 2003
Association of Chlamydia pneumoniae with central nervous system diseaseCharles W Stratton, Subramaniam Sriram
Clinical Therapeutics|June 11, 2004
Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001Charles W Stratton, Steven D Brown
Trends in Microbiology|September 26, 2006
Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniaeCharles W Stratton, David B Wheldon
The New England Journal of Medicine|August 6, 2005
Chlamydia pneumoniae and acute coronary syndromeWilliam M Mitchell, Charles W Stratton
The Journal of Thoracic and Cardiovascular Surgery|November 19, 2013
Efficacy of immunomodulation in the treatment of profound thrombocytopenia after adult cardiac surgeryJ Scott Rankin, Charles W Stratton
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Emerging Infectious Diseases|January 21, 2003
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistanceCharles W Stratton
The Medical Clinics of North America|November 23, 2006
In vitro susceptibility testing versus in vivo effectivenessCharles W Stratton
Expert Review of Anti-Infective Therapy|October 16, 2004
Antimicrobial resistance in respiratory tract pathogensCharles W Stratton
Postgraduate Medicine|August 12, 2009
Meeting the challenge of antibiotic resistance: The PROTEKT US studyCharles W Stratton
The Journal of Infectious Diseases|December 24, 2016
Phages, Fitness, Virulence, and Synergy: A Novel Approach for the Therapy of Infections Caused by Pseudomonas aeruginosaCharles W Stratton
Microbes and Infection|November 19, 2003
Association of Chlamydia pneumoniae with central nervous system diseaseCharles W Stratton, Subramaniam Sriram
Clinical Therapeutics|June 11, 2004
Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001Charles W Stratton, Steven D Brown
Trends in Microbiology|September 26, 2006
Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniaeCharles W Stratton, David B Wheldon
The New England Journal of Medicine|August 6, 2005
Chlamydia pneumoniae and acute coronary syndromeWilliam M Mitchell, Charles W Stratton
The Journal of Thoracic and Cardiovascular Surgery|November 19, 2013
Efficacy of immunomodulation in the treatment of profound thrombocytopenia after adult cardiac surgeryJ Scott Rankin, Charles W Stratton
Pageof 8